Entry |
|
Name |
Thrombin (JP18/USP/INN); Factor IIa; Thrombostat (TN) |
Product |
|
Class |
Blood modifier agent
DG02016 Hemostatics
DG02014 Blood coagulation accelerant
|
Remark |
Therapeutic category: | 3323 |
Product (DG00169): | D00090<JP/US> |
Product (mixture): | D08812<JP> D12591<JP/US> |
|
Efficacy |
Blood coagulation factor (enzyme), Hemostatic |
Comment |
|
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B02 ANTIHEMORRHAGICS
B02B VITAMIN K AND OTHER HEMOSTATICS
B02BC Local hemostatics
B02BC06 Thrombin
D00090 Thrombin (JP18/USP/INN) <JP/US>
B02BD Blood coagulation factors
B02BD30 Thrombin
D00090 Thrombin (JP18/USP/INN) <JP/US>
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
33 Blood and body fluid agents
332 Hemostatics
3323 Hemostatics for organs
D00090 Thrombin (JP18/USP/INN)
Drug groups [BR:br08330]
Blood modifier agent
DG02016 Hemostatics
DG02014 Blood coagulation accelerant
DG00169 Thrombin
D00090 Thrombin
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00090 Thrombin
Drug groups [BR:br08330]
Blood modifier agent
DG02016 Hemostatics
DG02014 Blood coagulation accelerant
DG00169 Thrombin
|
Other DBs |
|